Hypoxia-preconditioned mesenchymal stem cells ameliorate ischemia/reperfusion-induced lung injury.
Hypoxia preconditioning has been proven to be an effective method to enhance the therapeutic action of mesenchymal stem cells (MSCs). However, the beneficial effects of hypoxic MSCs in ischemia/reperfusion (I/R) lung injury have yet to be investigated. In this study, we hypothesized that the adminis...
Main Authors: | Yung-Yang Liu, Chi-Huei Chiang, Shih-Chieh Hung, Chih-Feng Chian, Chen-Liang Tsai, Wei-Chih Chen, Haibo Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5678873?pdf=render |
Similar Items
-
Hypoxia-preconditioned mesenchymal stem cells prevent renal fibrosis and inflammation in ischemia-reperfusion rats
by: Naoki Ishiuchi, et al.
Published: (2020-03-01) -
Hypoxic mesenchymal stem cells ameliorate acute kidney ischemia-reperfusion injury via enhancing renal tubular autophagy
by: Wei-Cheng Tseng, et al.
Published: (2021-06-01) -
Evolving spectrum of dexmedetomidine preconditioning for Ischemia–reperfusion injury amelioration
by: Jasvinder K Kohli, et al.
Published: (2020-01-01) -
Remote ischemic preconditioning STAT3-dependently ameliorates pulmonary ischemia/reperfusion injury.
by: Nanfu Luo, et al.
Published: (2018-01-01) -
Effect of ischemia preconditioning on renal ischemia/reperfusion injury in rats
by: Lian-hui Fan, et al.
Published: (2012-12-01)